Good-first: B/F/TAF As First-line ART

NCT06619288 · clinicaltrials.gov ↗

RECRUITING

Status

630

Enrollment

OTHER

Sponsor class

Conditions

HIV Infection

Interventions

DRUG: B/F/TAF
DRUG: TDF+3TC+EFV
DRUG: DTG/3TC

Sponsor

Affiliated Hospital of Nantong University

Collaborators

[object Object]